Journal of the Neurological Sciences 2001 - 2002: Vol 184-194 Index

21 Pages·4.3 MB·English

NeJouurnarl oof tlhe ogical
Sciences
LSEVIER
Journal of the Neurological Sciences 194 (2002) 93-106
www.elsevier.com /locate /jns
Cumulative Author Index (2002) Volumes 184—194
Aadland, S., see Aarskog, N.K. (188) 21 Arenas, J., see Aguilera, I. (192) 81
Aarskog, N.K., Aadland, S., Gjerde, 1.0. and Vedeler, C.A. Arimura, K., see Nakagawa, M. (185) 31
Molecular genetic analysis of Charcot—Marie—Tooth 1A duplication Arimura, K., see Matsuyama, W. (186) 75
in Norwegian patients by quantitative photostimulated luminescence Arndt, C., see De Seze, J. (188) 37
imaging (188) 21 Asano, M., see Matsuda, M. (184) 189
Aasly, J., see Oren, A. (186) 31 Asano, T., see Hanyu, H. (188) 79
Abe, K., see Hanyu, H. (188) 79 Asbury, A.K., see Ad Hoe Panel on Endpoints for Diabetic Neuropathy
Abe, K., see Murakami, T. (189) 45 Trials (189) 3
Abe, K., see Manabe, Y. (193) 13 Athanasiou, A., see Perunovic, B. (185) 55
Adachi, Y., see Mori, M. (185) 43 Auchus, A.P., see Tan, E.K. (190) 95
Adeér, H.J., see Kalkers, N.F. (184) 155 Auchus, A.P., see Tan, E.K. (193) 53
Adér, H.J., see Kalkers, N.F. (187) 111 Augustin, A., see Schmidt, S. (187) 49
Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials, Apfel, S.C., Avolio, C., Ruggieri, M., Cafforio, P.. Giuliani, F., Silvestris. F..
Asbury, A.K., Bril, V., Burns, T.M., Campbell, J.N., Chalk, C.H., Dammacco, F., Livrea, P. and Trojano, M.
Dyck, P.J., Dyck, P.J.B., Feldman, E.L., Fields, H.L.. Grant, LA., LFA-1 expression on CD4~ CD45RO™ peripheral blood T-lympho-
Griffin, J.W., Klein, C.J., Lindblom, U., Litchy, W.J., Low, P.A.. cytes in RR MS: effects induced by rIFNB-1la (186) 65
Melanson, M., Mendell, J.R., Merren, M.D. and O’Brien, P.C. Ayachi, M., see De Seze, J. (188) 37
Positive neuropathic sensory symptoms as endpoints in diabetic neu-
ropathy trials (189) 3
Aguilera, I., Garcia-Lozano, J.-R., Mufioz, A., Arenas, J., Campos, Y., Bakshi, R.. Dmochowski, J.. Shaikh, Z.A. and Jacobs, L.
Chinch6n, I., Roldan, A.-N. and Bautista, J. Gray matter T2 hypointensity is related to plaques and atrophy in the
Mitochondrial DNA point mutation in the COI gene in a patient with brains of multiple sclerosis patients (185) 19
McArdle’s disease (192) 81 Balestrieri, G., see Monastero, R. (184) 33
Aizawa, H., see Katayama, T. (193) 37 Ball, L.J., Willis, A.. Beukelman, D.R. and Pattee, G.L.
Akhmedova, S.N., Yakimovsky, A.K. and Schwartz, E.I. A protocol for identification of early bulbar signs in Amyotrophic
Paraoxonase | Met—Leu 54 polymorphism is associated with Parkin- Lateral Sclerosis (191) 43
son’s disease (184) 179 Balzarini, C.. see Mazzini, L. (191) 139
Akiguchi, I., see Mizutani, K. (188) 9 Barbero, P., see Durelli, L. (193) 17
Akiyama, H., see Togo, T. (184) 71 Barbieri, C.J., see Caselli, R.J. (189) 93
Al-Khalaf, A., see Grau, A.J. (192) 41 Bardoni, A., see Sironi, M. (186) 51
Albert, S.M., Murphy, P.L., Del Bene, M., Rowland, L.P. and Mit- Barkhof, F., see Kalkers, N.F. (184) 155
sumoto, H. Barkhof, F., see Kalkers, N.F. (187) 111
Incidence and predictors of PEG placement in ALS/MND (191) 115 Barlas, O., see Yilmaz, M. (186) 27
Alcazar, A., see Cid, C. (193) 103 Barohn, R., see Miller, R.G. (191) 127
Alcina, A., see Fedetz, M. (190) 69 Barohn, R.J., see Jackson, C.E. (191) 75
Alexander, G.E., see Caselli, R.J. (189) 93 Basile, A.M., see Di Carlo, A. (188) 85
Alexander, G.E., see Hampel. H. (194) 15 Bautista, J., see Aguilera, I. (192) 81
Alexander, G.M., see Deitch, J.S. (193) 117 Bayazit, Y.A., see Yilmaz, M. (186) 27
Alexander, M., see Thomas, S.V. (188) 73 Bayazit, Y.A., see Erdal, M.E. (188) 99
Alvarez-Cermeiio, J.C.. see Cid, C. (193) 103 Bayazit, Y.A., see Yilmaz, M. (184) 139
Amaike, M., see Namekawa, M. (185) 63 Bayer, W., see Hampel, H. (194) 15
Amaike, M., see Shimazaki, H. (185) 101 Becher, H., see Grau, A.J. (186) 1
Amari, M., see Hayashi, S. (188) 3 Becher, H., see Grau, A.J. (192) 41
Amoroso, A., see Masé, G. (191) 11 Behari, M., Srivastava, A.K., Das, R.R. and Pandey, R.M.
Anand, A., see Murgod, U.A. (190) 73 Risk factors of Parkinson’s disease in Indian patients (190) 49
Andersen, P.M., Grénberg, H., Franzen, L. and Funegard, U. Belden, D.S., see Sanjak, M. (191) 55
External radiation of the parotid glands significantly reduces drooling Bendotti, C., Calvaresi, N., Chiveri, L., Prelle, A.. Moggio, M., Braga,
in patients with motor neurone disease with bulbar paresis (191) 111 M., Silani, V. and De Biasi, S.
Andersson, T., see Press, R. (190) 41 Early vacuolization and mitochondrial damage in motor neurons of
Ando, Y., see Namekawa, M. (187) 103 FALS mice are not associated with apoptosis or with changes in
Apfel, S.C., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy cytochrome oxidase histochemical reactivity (191) 25
Trials (189) 3 Benna, P., see Montalenti, E. (184) 65
Arahata, K., see Nakagawa, M. (184) 15 Bensimon, G., see Spreux-Varoquaux, O. (193) 73
PII: S0022-510X(02)00011-4
94 Cumulative Author Index (2002) Volumes 184—194
Berciano, J., Mateo, I., De Pablos, C., Polo, J.M. and Combarros, O. Buggle, F., see Grau, A.J. (186) |
Friedreich ataxia with minimal GAA expansion presenting as adult- Buggle, F., see Grau, A.J. (192) 41
onset spastic ataxia (194) 75 Bughin, M., see De Seze, J. (188) 37
Bergamaschi, R., Berzuini, C., Romani, A. and Cosi, V. Burchardt, F., see Lee, J.N. (191) 79
Predicting secondary progression in relapsing—remitting multiple scle- Burns, T.M., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
rosis: a Bayesian analysis (189) 13 Trials (189) 3
Bergamasco, B., see Montalenti, E. (184) 65 Burrell, A., see Kiebert, G.M. (191) 87
Bergamasco, B., see Perozzo, P. (192) 9 Biischer, P., see Bisser, S. (193) 127
Bergamasco, B., see Durelli, L. (193) 17
Bergmann, C., see Senderek, J. (192) 49 Cafforio, P., see Avolio, C. (186) 65
Bertorini, T.E., see Narayanaswami, P. (184) 11 Cagliani, R., see Sironi, M. (186) 51
Bertram, M., see Grau, A.J. (192) 41 Caimi, G., Canino, B., Ferrara, F., Montana, M., Musso, M., Porretto, F.,
Berzuini, C., see Bergamaschi, R. (189) 13 Carollo, C., Catania, A. and Lo Presti, R.
Bettini, P., see Monastero, R. (184) 33 Granulocyte integrins before and after activation in acute ischaemic
Beukelman, D.R., see Ball, L.J. (191) 43 stroke (186) 23
Bhalla, A., see Hajat, C. (190) 79 Caligari, M., see Mazzini, L. (191) 139
Bianchi, S., see Inglese, M. (188) 33 Calvaresi, N., see Bendotti, C. (191) 25
Biondi, E., see Di Carlo, A. (188) 85 Camarda, R., see Monastero, R. (184) 33
Birnbaum, M., see Drory, V.E. (190) 17 Campanella, G., see Perretti, A. (192) 35
Bisser, S., Lejon, V., Preux, P.M., Bouteille, B.. Stanghellini, A., Campbell, J.N., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
Jauberteau, M.O., Biischer, P. and Dumas, M. Trials (189) 3
Blood—cerebrospinal fluid barrier and intrathecal immunoglobulins Campos, Y., see Aguilera, I. (192) 81
compared to field diagnosis of central nervous system involvement in Canino, B., see Caimi, G. (186) 23
sleeping sickness (193) 127 Capello, E., see Mancardi, G. (184) 41
Block, W., see Pohl, C. (190) 21 Capobianco, A., see Comoletti, D. (192) 61
Blumhardt, L.D.. see Lin, X. (189) 99 Carbonetto, F., see Di Carlo, A. (188) 85
Bogousslavsky, J., see De Freitas, G.R. (193) 43 Carollo, C., see Caimi, G. (186) 23
Bokde, A.L.W., Teipel, S.J.. Zebuhr, Y., Leinsinger, G., Gootjes, L., Carpén, O., see Sairanen, T.R. (186) 87
Schwarz, R., Buerger, K., Scheltens, P.. Moeller, H.-J. and Hampel, Carraro, N., see Mase, G. (191) 11
H. Caselli, R.J., Osborne, D., Reiman, E.M., Hentz, J.G., Barbieri, C.J.,
A new rapid landmark-based regional MRI segmentation method of Saunders, A.M., Hardy, J., Graff-Radford, N.R., Hall, G.R. and
the brain (194) 35 Alexander, G.E.
Bonacchi, M., see Di Carlo, A. (188) 85 Preclinical cognitive decline in late middle-aged asymptomatic apo-
Bonfigli, L., see Mase, G. (191) 11 lipoprotein E-e4/4 homozygotes: a replication study (189) 93
Boniotto, M., see Masé, G. (191) 11 Castelli, L., see Perozzo, P. (192) 9
Bontrop, R., see Mancardi, G. (184) 41 Cataloluk, O., see Yilmaz, M. (186) 27
Borasio, G.D., see Neudert, C. (191) 103 Catania, A., see Caimi, G. (186) 23
Borasio, G.D., see Wasner, M. (191) 151 Cattaneo, R., see Monastero, R. (184) 33
Bortolomasi, M., see Manganotti, P. (184) 27 Cazzato, G., see Zorzon, M. (187) |
Bouche, P., see Le Forestier, N. (185) 95 Cazzato, G., see Masé, G. (191) 11
Bouteille, B., see Bisser, S. (193) 127 Chalk, C.H., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
Boyden, J.W., see Greenlee, J.E. (184) 131 Trials (189) 3
Bracco, L., see Di Carlo, A. (188) 85 Chan, L.L., see Tan, E.K. (193) 53
Bradley, W., see Miller, R.G. (191) 127 Chang, C.-P., see Tsai, C.-H. (190) 35
Bradley, W.G., see Mowzoon, N. (185) 119 Chang, J.-G., see Tsai, C.-H. (190) 35
Braga, M., see Bendotti, C. (191) 25 Changes, E.T.F.A.-R.W.M., see De Reuck, J. (193) 1
Brahmachari, S.K., see Murgod, U.A. (190) 73 Chapman, J., see Wang, N. (184) 183
Brambilla, D., see Montirosso, R. (194) 3 Chapman, J., see Drory, V-E. (190) 17
Brandt, T., see Grau, A.J. (186) | Chen, C.-M., see Tsai, C.-H. (190) 35
Brashear, H.R., see Greenlee, J.-E. (184) 131 Chen, J., Li, Y.. Wang, L., Lu, M., Zhang, X. and Chopp, M.
Brenner, M., see Sairanen, T.R. (186) 87 Therapeutic benefit of intracerebral transplantation of bone marrow
Bresolin, N., see Sironi, M. (186) 51 stromal cells after cerebral ischemia in rats (189) 49
Bresolin, N., see Montirosso, R. (194) 3 Chen, J., see Li, Y. (193) 137
Brierley, C.M.H., see Hickman, S.J. (187) 35 Chida, K., see Kikuchi, A. (193) 29
Bril, V., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials Chihara, K., see Yoshihara, T. (184) 149
(189) 3 Chinchon, I., see Aguilera, I. (192) 81
Brinkmann, J., see Sanjak, M. (191) 55 Chid, A., Silani, V. and Italian ALS Study Group
Brok, H., see Mancardi, G. (184) 41 Amyotrophic lateral sclerosis care in Italy: a nationwide study in
Bromberg, M.B., Fries, T.J., Forshew, D.A. and Tandan, R. neurological centers (191) 145
Electrophysiologic endpoint measures in a multicenter ALS drug trial Chiveri, L., see Bendotti, C. (191) 25
(184) 51 Choksi, R., see Lopate, G. (188) 67
Brooks, B.R., see Sanjak, M. (191) 55 Chopp, M., see Chen, J. (189) 49
Brossa, P.C., see Durelli, L. (193) 17 Chopp, M., see Li, Y. (193) 137
Bryan, W., see Miller, R.G. (191) 127 Christen-Ziich, S., see De Freitas, G.R. (193) 43
Bryan, W.W., see Jackson, C.E. (191) 75 Chu, K., Kang, D.-W., Kim, D.-E. and Roh, J.-K.
Buerger, K., see Bokde, A.L.W. (194) 35 Cerebral venous thrombosis associated with tentorial subdural
Bufler, J.. see Krampfl, K. (191) 19 hematoma during oxymetholone therapy (185) 27
Cumulative Author Index (2002) Volumes 184—194
Cid, C., Aledzar, A., Regidor, I., Masjuan, J., Salinas, M. and Alvarez- Del Valle, L.. see Deitch, J.S. (193) 117
Cermeno, J.C. Del Zotto, E., see Monastero, R. (184) 33
Neuronal apoptosis induced by cerebrospinal fluid from multiple De Masi, R., see Zorzon, M. (187) |
sclerosis patients correlates with hypointense lesions on Tl magnetic Dengler, R., see Krampfl, K. (191) 19
resonance imaging (193) 103 De Pablos, C., see Berciano, J. (194) 75
Clausen, J., see Rasmussen, H.B. (184) 143 De Reuck, J., Santens, P., Strijckmans, K., Lemahieu, I. and Changes,
Clawson, S.A., see Greenlee, J.E. (184) 131 E.T.F.A.-R.W.M.
Codella, M., Rocca, M.A., Colombo, B., Martinelli-Boneschi, F., Comi, Cobalt-55 positron emission tomography in vascular dementia: signif-
G. and Filippi, M. icance of white matter changes (193) |
Cerebral grey matter pathology and fatigue in patients with multiple De Seze, J., Arndt, C., Stojkovic, T., Ayachi, M., Gauvrit, J.Y.. Bughin,
sclerosis: a preliminary study (194) 71 M., Saint Michel, T., Pruvo, J.P., Hache, J.C. and Vermersch, P.
Coglitore, S., see Vita, G. (186) 45 Pupillary disturbances in multiple sclerosis: correlation with MRI
Colombo, B., see Codella, M. (194) 71 findings (188) 37
Colombo, R., see Mazzini, L. (191) 139 DesRosiers, M., see Melun, J.-P. (186) 107
Combarros, O., see Berciano, J. (194) 75 Dib, M., see Spreux-Varoquaux, O. (193) 73
Comi, G.P., see Sironi, M. (186) 51 Di Carlo, A., Perna, A.M., Pantoni, L., Basile, A.M., Bonacchi, M.,
Comi, G., see Inglese, M. (188) 33 Pracucci, G., Trefoloni, G., Bracco, L., Sangiovanni, V., Piccim, C.,
Comi, G., see Codella, M. (194) 71 Palmarini, M.F., Carbonetto, F., Biondi, E., Sani, G. and Inzitari, D.
Comoletti, D., Muzio, V., Capobianco, A., Ravizza, T. and Mennini, T. Clinically relevant cognitive impairment after cardiac surgery: a
Nitric oxide produced by non-motoneuron cells enhances rat embry- 6-month follow-up study (188) 85
onic motoneuron sensitivity to excitotoxins: comparison in mixed Di Leo, R., see Vita, G. (186) 45
neuron/ glia or purified cultures (192) 61 DiMauro, S., see Hadjigeorgiou, G.M. (194) 83
Compston, D.A.S., see Hickman, S.J. (187) 35 Diomedi, M., Cupini, L.M., Rizzato, B., Ferrante, F., Giacomini, P. and
Coshall, C., see Hajat, C. (190) 79 Silvestrini, M.
Cosi, V., see Bergamaschi, R. (189) 13 Influence of physiologic oscillation of estrogens on cerebral hemody-
Cosi, V., see Franciotia, D. (190) 11 namics (185) 49
Cotelli, M., see Meola, G. (193) 89 Dmochowski, J., see Bakshi, R. (185) 19
Cottini, E., see Monastero, R. (184) 33 Dondi, E., see Franciotta, D. (190) 11
Crovella, S., see Masé, G. (191) 11 Dotti, M.T., see Mondelli, M. (190) 29
Cucchiara, B. and Kasner, S.E. Dougan, C., see Lee, J.N. (191) 79
Use of statins in CNS disorders (187) 81 Dronsky, V., see Miller, R.G. (191) 127
Cuccia, M., see Franciotta, D. (190) 11 Drory, V.E., Birnbaum, M., Korezyn, A.D. and Chapman, J.
Cui, L., see Wang, H. (194) 49 Association of APOE e4 allele with survival in amyotrophic lateral
Cupini, L.M., see Diomedi, M. (185) 49 sclerosis (190) 17
Drory, V.E., Goltsman, E., Goldman Reznik, J., Mosek, A. and Korezyn,
A.D.
Dammacco, F., see Avolio, C. (186) 65 The value of muscle exercise in patients with amyotrophic lateral
Das, R.R., see Behari, M. (190) 49 sclerosis (191) 133
Davis, D.G., see Winters, J.L. (188) 13 Dumas, M.., see Bisser, S. (193) 127
Davis, L.E. and Kornfeld, M. Durelli, L., Oggero, A., Verdun, E., Isoardo, G.L., Barbero, P., Bergam-
Experimental influenza B viral myositis (187) 61 asco, B., Brossa, P.C., Ghigo, E., Maccario, M., Faggiano, F. and The
Day, A.L., see He, Z. (193) 79 Betaferon” Safety Trial (BEST) Study Group
De Ambroggi, L., see Meola, G. (193) 89 Thyroid function and anti-thyroid antibodies in MS patients screened
De Ambrogio, R., see Mazzini, L. (191) 139 for interferon treatment. A multicenter study (193) 17
De Biasi, S., see Bendotti, C. (191) 25 Dyck, P.J., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
DeFor, T.A., see Liu, X.-F. (187) 91 Trials (189) 3
De Freitas, G.R., Miklossy, J., Christen-Zich, S., Reichhart, M. and Dyck, P.J.B., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
Bogousslavsky, J. Trials (189) 3
A CADASIL case with normal skin biopsy and without mutations in Dziedzic, T., see Szcezudlik, A. (189) 105
exons 3 and 4 of the Notch3 gene (193) 43
De Gregorio, C., see Vita, G. (186) 45 Eisen, A., see Stewart, H. (191) 67
Deguchi, K., Takeuchi, H., Sasaki, I., Tsukaguchi, M., Touge, T. and Eisensehr, I., V Lindeiner, H., Jager, M. and Noachtar, S.
Nishioka, M. REM sleep behavior disorder in sleep-disordered patients with versus
Impaired novelty P3 potentials in multiple system atrophy—correla- without Parkinson’s disease: is there a need for polysomnography?
tion with orthostatic hypotension (190) 61 (186) 7
Dehmeshki, J., Silver, N.C., Leary, S.M., Tofts, P.S., Thompson, A.J. and Elovaara, I., see Luomala, M. (185) 123
Miller, D.H. Engvall, E., see O’Brien, D.P. (189) 37
Magnetisation transfer ratio histogram analysis of primary progressive Enomoto-Nakatani, S., see Hagiwara, H. (193) 59
and other multiple sclerosis subgroups (185) 11 Erbagci, I., see Yilmaz, M. (184) 139
Deitch, J.S., Alexander, G.M., Del Valle, L. and Heiman-Patterson, T.D. Erdal, M.E., Herken, H., Yilmaz, M. and Bayazit, Y.A.
GLT-1 glutamate transporter levels are unchanged in mice expressing Association of the T102C polymorphism of 5-HT2A receptor gene
G93A human mutant SOD] (193) 117 with aura in migraine (188) 99
Del Bene, M., see Albert, S.M. (191) 115 Erdal, M.E., see Yilmaz, M. (186) 27
Del Bigio, M.R., Yan, H.-J. and Xue, M.
Intracerebral infusion of a second-generation ciliary neurotrophic Faggiano, F., see Durelli, L. (193) 17
factor reduces neuronal loss in rat striatum following experimental Farkkilaé, M., see Rantalaiho, T. (184) 169
intracerebral hemorrhage (192) 53 Fawcett, J.R., see Liu, X.-F. (187) 91
96 Cumulative Author Index (2002) Volumes 184—194
Federico, A., see Mondelli, M. (190) 29 Giacomini, P., see Diomedi, M. (185) 49
Fedetz, M., Matesanz, F., Pascual, M., Martin, J.. Fernandez, O., Guer- Giacopuzzi, M., see Manganotti, P. (184) 27
rero, M. and Alcina, A. Gill, J.S., see Russell, J.W. (192) 71
The — 174/— 597 promoter polymorphisms in the interleukin-6 gene Giovanardi, F., see Guidetti, D. (184) 203
are not associated with susceptibility to multiple sclerosis (190) 69 Giuliani, F., see Avolio, C. (186) 65
Feldman, E.L., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy Giunti, D., see Mancardi, G. (184) 41
Trials (189) 3 Gjerde, I.0., see Aarskog, N.K. (188) 21
Felisari, G., see Sironi, M. (186) 51 Glosser, G., see Grossman, M. (184) 123
Felisari, G., see Montirosso, R. (194) 3 Goldman Reznik, J., see Drory, V-E. (191) 133
Fellner, C., see Hecht, M.J. (186) 37 Goltsman, E., see Drory, V.E. (191) 133
Fellner, F., see Hecht, M.J. (186) 37 G6mez-Ramos, P., see Garefa Gil, M.L. (192) 27
Fernandez, O., see Fedetz, M. (190) 69 Gootjes, L., see Bokde, A.L.W. (194) 35
Ferrante, F., see Diomedi, M. (185) 49 Goto, J., see Hashida, H. (190) 87
Ferrara, F., see Caimi, G. (186) 23 Goto, K., see Nakagawa, M. (184) 15
Fiaschi, A., see Manganotti, P. (184) 27 Goto, K., see Noda, K. (188) 95
Fields, H.L., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy Gourie-Devi, M., see Shahani, N. (185) 109
Trials (189) 3 Grad, A., see Megli¢, B. (185) 135
Filippi, M. Graff-Radford, N.R., see Caselli, R.J. (189) 93
Multiple sclerosis: a white matter disease with associated gray matter Grant, I.A., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
damage (185) 3 Trials (189) 3
Filippi, M., see Inglese, M. (188) 33 Grau, A.J., Buggle, F., Lichy, C., Brandt, T., Becher, H. and Rudi, J.
Filippi. M., see Codella, M. (194) 71 Helicobacter pylori infection as an independent risk factor for cere-
Filipponi, E., see Montirosso, R. (194) 3 bral ischemia of atherothrombotic origin (186) 1
Flabouriari, K., see Hadjigeorgiou, G.M. (194) 83 Grau, A.J., Reis, A.. Buggle, F., Al-Khalaf, A.. Werle, E., Valois, N.,
Forshew, D.A., see Bromberg, M.B. (184) 51 Bertram, M., Becher, H. and Grond-Ginsbach, C.
Franciotta, D., Cuccia, M., Dondi, E., Piccolo, G. and Cosi, V. Monocyte function and plasma levels of interleukin-8 in acute is-
Polymorphic markers in MHC class II/III region: a study on Italian chemic stroke (192) 41
patients with myasthenia gravis (190) 11 Graus, F., see Megli¢, B. (185) 135
Francis, D.A., see Rasmussen, H.B. (184) 143 Green, C., see Kiebert, G.M. (191) 87
Franzen, L., see Andersen, P.M. (191) 111 Greenlee, J.E.. Boyden, J.W., Pingree, M., Brashear, H.R., Clawson, S.A.
Frey Il, W.H., see Liu, X.-F. (187) 91 and Keeney, P.M.
Fries, T.J., see Bromberg, M.B. (184) 51 Antibody types and IgG subclasses in paraneoplastic neurological
Fujihara, K., see Shimizu, H. (185) 39 syndromes (184) 131
Fujihara, K., see Tateyama, M. (194) 29 Griffin, J.W., see Ad Panel on Endpoints for Diabetic Neuropathy Trials
Fujii, K.. see Toyoda, K. (193) 147 (189) 3
Fujimoto, H., Kaneko, K.. Taguchi, T.. Ofuji, A.. Yonemura, H. and Groeneveld, G.J.. Van Kan, H.J.M., Sastre Toraftio, J... Veldink, J.H.,
Kawai, S. Guchelaar, H.-J., Wokke, J.H.J. and Van den Berg, L.H.
Differential recording of upper and lower cervical N13 responses and Inter- and intraindividual variability of riluzole serum concentrations
their contribution to scalp recorded responses in median nerve so- in patients with ALS (191) 121
matosensory evoked potentials (187) 17 Grénberg, H., see Andersen, P.M. (191) 111
Fujimoto, K.-i., see Namekawa, M. (187) 103 Grond-Ginsbach, C., see Grau, A.J. (192) 41
Fujimoto, S., see Shimazaki, R. (194) 55 Grossman, M., Glosser, G., Kalmanson, J., Morris, J., Stern, M.B. and
Fujishima, K., see Noda, K. (188) 95 Hurtig, H.L1.
Fukae, J., see Noda, K. (188) 95 Dopamine supports sentence comprehension in Parkinson’s Disease
Fukuda, H., see Kikuchi, A. (193) 29 (184) 123
Fukui, T., Hasegawa, Y. and Takenaka, H. Grothe, C., see Pohl, C. (190) 21
Hyperthyroid dementia: clinicoradiological findings and response to Guchelaar, H.-J., see Groeneveld, G.J. (191) 121
treatment (184) 81 Guerrero, M., see Fedetz, M. (190) 69
Fukuuchi, Y., see Suzuki, S. (189) 59 Guidetti, D., Pisanello, A.. Giovanardi, F., Morandi, C., Zuccoli, G. and
Funegard, U., see Andersen, P.M. (191) 111 Troiso, A.
Furusawa, K., see Tomiyama, M. (189) 65 Spontaneous carotid dissection presenting lower cranial nerve palsies
Furuya, H., see Horiuchi, I. (193) 49 (184) 203
Furuya, H., see Oishi, A. (193) 151 Guo, L.T., see O’Brien, D.P. (189) 37
Ganslandt, O., see Kamada, K. (186) 13 Hache, J.C., see De Seze, J. (188) 37
Garcia-Lozano, J.-R., see Aguilera, I. (192) 81 Hadjigeorgiou, G.M., Papadimitriou, A., Musumeci, O., Paterakis, K.,
Garcia Gil, M.L., Moran, M.A. and Gémez-Ramos, P. Flabouriari, K., Shanske, S. and DiMauro, S.
Ubiquitinated granular structures and initial neurofibrillary changes in A new stop codon mutation (Y52X) in the myophosphorylase gene in
the human brain (192) 27 a Greek patient with McArdle’s disease (194) 83
Gauvrit, J.Y., see De Seze, J. (188) 37 Hagiwara, H., Enomoto-Nakatani, S., Sakai, K., Ugawa, Y., Kusunoki, S.
Gelinas, D., see Jackson, C.E. (191) 75 and Kanazawa, I.
Gelinas, D.F., see Miller, R.G. (191) 127 Stiff-person syndrome associated with invasive thymoma: a case
Gemignani, F. and Marbini, A. report (193) 59
Charcot—Marie—Tooth disease (CMT): distinctive phenotypic and Hajat, C., Coshall, C., Rudd, A.G., Patel, M., Bhalla, A., Howard, R. and
genotypic features in CMT type 2 (184) | Wolfe, C.D.A.
Gemma, A., see Mase, G. (191) 11 The inter- and intraobserver reliabilities of a new classification system
Ghigo, E., see Durelli, L. (193) 17 for ischaemic stroke: the South London Stroke Register (190) 79
Cumulative Author Index (2002) Volumes 184—194
Hall, G.R., see Caselli, R.J. (189) 93 Hogan, E.L., see Lo, H.-S. (194) 11
Hiimildinen, P., see Laatu, S. (185) 77 Honjo, K., see Naka, H. (193) 111
Hampel, H., Teipel, S.J.. Bayer, W., Alexander, G.E., Schwarz, R.. Hopf, H.C., see Urban, P.P. (186) 59
Schapiro, M.B., Rapoport, S.I. and MGller, H.-J. Horiuchi, I., Ochi, H., Murai, H.. Osoegawa, M., Minohara, M., Furuya,
Age transformation of combined hippocampus and amygdala volume H. and Kira, J.-i.
improves diagnostic accuracy in Alzheimer’s disease (194) 15 Th2 shift in mononeuritis multiplex and increase of Th2 cells in
Hampel, H., see Bokde, A.L.W. (194) 35 chronic inflammatory demyelinating polyneuropathy: an intracellular
Hanyu, H., Asano, T., Sakurai, H., Takasaki, M., Shindo, H. and Abe, K. cytokine analysis (193) 49
Magnetization transfer measurements of the hippocampus in the early Howard, R., see Hajat, C. (190) 79
diagnosis of Alzheimer’s disease (188) 79 Hu, C.-J., see Tsai, C.-H. (190) 35
Haraguchi, T., see Yokota, O. (194) 41 Hu, J., see Ono, S. (187) 27
Hardy, J., see Caselli, R.J. (189) 93 Huang, N., see Nitrini, R. (184) 163
Harness, J., Pender, M.P. and McCombe, P.A. Hung, Y.-C., see Lee, E.-J. (190) 3
Cyclosporin A treatment modulates cytokine mRNA expression by Hurme, M., see Luomala, M. (185) 123
inflammatory cells extracted from the spinal cord of rats with experi- Hurtig, H.1., see Grossman, M. (184) 123
mental autoimmune encephalomyelitis induced by inoculation with
myelin basic protein (187) 7
Hart, B., see Mancardi, G. (184) 41 lannaccone, S., see Miller, R.G. (191) 127
Hasegawa, Y., see Fukui, T. (184) 81 Ibayashi, S., see Toyoda, K. (193) 147
Hashida, H., Goto, J., Suzuki, T., Jeong, S.-Y., Masuda, N., Ooie, T., Ichikawa, M., see Inaba, Y. (185) 89
Tachiiri, Y., Tsuchiya, H. and Kanazawa, I. Ichimura, M., see Hattori, N. (184) 57
Single cell analysis of CAG repeat in brains of dentatorubral-palli- Ikeda, K., see Yokota, O. (194) 41
doluysian atrophy (DRPLA) (190) 87 Ikeda, S.-i., see Matsuda, M. (184) 189
Hashiguchi, T., see Matsuyama, W. (186) 75 Imai, T., see Ono, S. (187) 27
Hashimoto, K., see Katayama, T. (193) 37 Imai, Y., see Manabe, Y. (193) 13
Hattori, N.. Misu, K., Koike, H., Ichimura, M., Nagamatsu, M.. Hi- Imon, Y., see Naka, H. (193) 111
rayama, M. and Sobue, G. Imperiale, D., see Montalenti, E. (184) 65
Age of onset influences clinical features of chronic inflammatory Inaba, Y.. Ichikawa, M., Inoue, A., Itoh, M., Kyogashima, M., Sekiguchi,
demyelinating polyneuropathy (184) 57 Y., Nakamura, S., Komiyama, A. and Koh, C.-S.
Hattori, N., see Yoshihara, T. (184) 149 Plasma thrombin—antithrombin I] complex is associated with the
Hattori, T., see Sakakibara, R. (187) 55 severity of experimental autoimmune encephalomyelitis (185) 89
Hayashi, S., Sakurai, A., Amari, M. and Okamoto, K. Inglese, M., Rovaris, M., Bianchi, S.. Comi, G. and Filippi, M.
Pathological study of the diffuse myelin pallor in the anterolateral Magnetization transfer and diffusion tensor MR imaging of the optic
columns of the spinal cord in amyotrophic laterai sclerosis (188) 3 radiations and calcarine cortex from patients with Leber’s hereditary
Hayashi, T., see Murakami, T. (189) 45 optic neuropathy (188) 33
Hayashi, T., see Manabe, Y. (193) 13 Inoue, A., see Inaba, Y. (185) 89
He, Y.-J.. see He, Z. (193) 79 Inoue, M., see Yoshida, T. (184) 77
He, Z., He, Y.-J., Day, A.L. and Simpkins, J.W. Inzitari, D., see Di Carlo, A. (188) 85
Proestrus levels of estradiol during transient global cerebral ischemia Iseki, E., Kato, M., Marui, W., Uéda, K. and Kosaka, K.
improves the histological outcome of the hippocampal CAI region: A neuropathological study of the disturbance of the nigro-amygdaloid
perfusion-dependent and-independent mechanisms (193) 79 connections in brains from patients with dementia with Lewy bodies
Heberlin, L., see Jackson, C.E. (191) 75 (185) 129
Hecht, M.J., Fellner, F., Fellner, C., Hilz, M.J.. Heuss, D. and Neundorfer, Iseki, E.. see Togo, T. (184) 71
B. Iseki, E., see Shiozaki, K. (193) 23
MRI-FLAIR images of the head show corticospinal tract alterations in Ishida, K., Takeuchi, H., Takahashi, R., Yoshimura, K.. Yamada, M. and
ALS patients more frequently than T2-, Tl- and proton-density- Mizusawa, H.
weighted images (186) 37 A possible novel isoform of peripheral myelin PO protein: a target
Heiman-Patterson, T.D., see Deitch, J.S. (193) 117 antigen recognized by an autoantibody in a patient with malignant
Hentz, J.G., see Caselli, R.J. (189) 93 lymphoma and peripheral neuropathy (188) 43
Herken, H., see Yilmaz, M. (186) 27 Ishigame, H., see Matsuda, M. (184) 189
Herken, H., see Erdal, M.E. (188) 99 Ishihara, H., see Yoshihara, T. (184) 149
Heuss, D., see Hecht, M.J. (186) 37 Ishii, N., see Tateyama, M. (194) 29
Hickman, S.J., Brierley, C.M.H., Silver, N.C., Moseley, I.F., Scolding, Ishikawa, M., Sekizuka, E., Oshio, C., Sato, S., Yamaguchi, N., Terao,
N.J., Compston, D.A.S. and Miller, D.H. S., Tsukada, K., Minamitani, H. and Kawase, T.
Infratentorial hypointense lesion volume on Tl-weighted magnetic Platelet adhesion and arteriolar dilation in the photothrombosis: obser-
resonance imaging correlates with disability in patients with chronic vation with the rat closed cranial and spinal windows (194) 59
cerebellar ataxia due to multiple sclerosis (187) 35 Ishizu, H., see Yokota, O. (194) 41
Higo, R., see Yamasoba, T. (187) 69 Iskra, T., see Szezudlik, A. (189) 105
Higuchi, I., see Nakagawa, M. (184) 15 Isoardo, G.L., see Durelli, L. (193) 17
Hilz, M.J., see Hecht, M.J. (186) 37 Italian ALS Study Group, see Chid, A. (191) 145
Hino, H., see Shiozaki, K. (193) 23 Itoh, M., see Inaba, Y. (185) 89
Hintzen, R.Q., see Kalkers, N.F. (184) 155 Itoyama, Y., see Shimizu, H. (185) 39
Hintzen, R.Q., see Kalkers, N.F. (187) 111 Itoyama, Y., see Kikuchi, A. (193) 29
Hirano, T., see Toyoda, K. (193) 147 Itoyama, Y., see Tateyama, M. (194) 29
Hirata, K., see Susuki, K. (185) 5 ludice, A., see Siciliano, G. (191) 61
Hirayama, M., see Hattori, N. (184) 57 Iwatsuki, K., see Manabe, Y. (193) 13
98 Cumulative Author Index (2002) Volumes 184—194
Jackson, C.E., Rosenfeld, J.. Moore, D.H., Bryan, W.W., Barohn, R.J.. Kaufmann, K. and Thiel, G.
Wrench, M., Myers, D., Heberlin, L., King, R., Smith, J., Gelinas, D. Epidermal growth factor and platelet-derived growth factor induce
and Miller, R.G. expression of Egr-/, a zinc finger transcription factor, in human
A preliminary evaluation of a prospective study of pulmonary func- malignant glioma cells (189) 83
tion studies and symptoms of hypoventilation in ALS/MND patients Kawabata, K., see Okuda, B. (187) 99
(191) 75 Kawabata, M., see Matsuyama, W. (186) 75
Jackson, P.F., see Zhang, W. (194) 21 Kawai, K., see Yokota, O. (194) 41
Jacobs, L., see Bakshi, R. (185) 19 Kawai, S., see Fujimoto, H. (187) 17
Jager, M., see Eisensehr, I. (186) 7 Kawakami, Y., see Suzuki, S. (189) 59
Jain, S.. see Murgod, U.A. (190) 73 Kawase, T., see Ishikawa, M. (194) 59
Jauberteau, M.O., see Bisser, S. (193) 127 Kawashima, R., see Kikuchi, A. (193) 29
Jeong, S.-Y., see Hashida, H. (190) 87 Kawata, A., see Tanaka, M. (188) 61
Jhoo, J.H.. Kim, K.W., Lee, D.Y., Lee, &K.U., Lee, J.H., Kim, S.Y., Keeney, P.M., see Greenlee, J.E. (184) 131
Youn, J.Y.. Youn, J.C. and Woo, J.1. Keilmann, A., see Urban, P.P. (186) 59
Association of alpha-2-macroglobulin deletion polymorphism with Kelly, M.A., see Rasmussen, H.B. (184) 143
sporadic Alzheimer’s disease in Koreans (184) 21 Kiebert, G.M., Green, C., Murphy, C., Mitchell, J.D.. O’Brien, M..,
Jia, L., see Yu, K. (189) 23 Burrell, A. and Leigh, P.N.
Johnson, G.C., see O’Brien, D.P. (189) 37 Patients’ health-related quality of life and utilities associated with
Jong. Y.-J., see Tsai, C.-H. (190) 35 different stages of amyotrophic lateral sclerosis (191) 87
Josephson, S.A., Schmidt, R.E., Millsap, P.. McManus, D.Q. and Morris, Kikuchi, A., Takeda, A., Kimpara, T., Nakagawa, M., Kawashima, R..,
a. Sugiura, M., Kinomura, S., Fukuda, H., Chida, K., Okita, N., Takase,
Autosomal dominant Kufs’ disease: a cause of early onset dementia S. and Itoyama, Y.
(188) 51 Hypoperfusion in the supplementary motor area, dorsolateral pre-
Jurjevic, A., see Masé, G. (191) 11 frontal cortex and insular cortex in Parkinson’s disease (193) 29
Kikuchi, K., see Katayama, T. (193) 37
Kikuchi, S., see Yamasoba, T. (187) 69
Kafri, M., see Wang, N. (184) 183 Kim, D.-E., see Chu, K. (185) 27
Kaji, R., see Mizutani, K. (188) 9 Kim, K.W., see Jhoo, J.H. (184) 21
Kalita, J., see Misra, U.K. (190) 57 Kim, S.Y., see Jhoo, J.H. (184) 21
Kalkers, N.F., Hintzen, R.Q.. Van Waesberghe, J.H.T.M., Lazeron, Kimpara, T., see Kikuchi, A. (193) 29
R.H.C.. Van Schijndel, R.A., Adér, H.J., Polman, C.H. and Barkhof, Kimura, T., see Tomiyama, M. (189) 65
F: Kimura, T., see Katayama, T. (193) 37
Erratum to **Magnetization transfer histogram parameters reflect all King, R., see Jackson, C.E. (191) 75
dimensions of MS pathology, including atrophy”’ [J. Neurol. Sci. 184 Kinomura, S., see Kikuchi, A. (193) 29
(2001) 155-162] (187) 111 Kinoshita, M., see Nemoto, H. (193) 7
Kalkers, N.F., Hintzen, R.Q., Van Waesberghe, J.H.T.M., Lazeron, Kira, J.-i., see Tanaka, M. (188) 61
R.H.C., Van Schijndel, R.A., Adér, H.J., Polman, C.H. and Barkhof, Kira, J.-i., see Horiuchi, I. (193) 49
F. Kira, J.-i., see Oishi, A. (193) 151
Magnetization transfer histogram parameters reflect all dimensions of Kiritoshi, S., see Toyoda, K. (193) 147
MS pathology, including atrophy (184) 155 Kissel, J.. see Miller, R.G. (191) 127
Kalmanson, J., see Grossman, M. (184) 123 Kitamura, T., see Naka, H. (193) 111
Kaltenhiiuser, M., see Kamada, K. (186) 13 Klein, C., see Kushnir, M. (186) 101
Kamada, K., Moller, M.. Saguer, M., Ganslandt, O., Kaltenhauser, M., Klein, C.J.. see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
Kober, H. and Vieth, J. Trials (189) 3
A combined study of tumor-related brain lesions using MEG and Klier, H., see Wasner, M. (191) 151
proton MR spectroscopic imaging (186) 13 Klockgether, T., see Schmidt, S. (187) 49
Kamakura, K., see Yoshida, T. (184) 77 Klockgether, T., see Pohl, C. (190) 21
Kametani, F., Tanaka, K.. Usami, M., Maruyama, K. and Mori, H. Kobayashi, Y., see Yoshida, T. (184) 77
Human wild presenilin-1 mimics the effect of the mutant presenilin-1 Kober, H., see Kamada, K. (186) 13
on the processing of Alzheimer’s amyloid precursor protein in PC12D Koh, C.-S., see Inaba, Y. (185) 89
cells (188) 27 Koike, H., see Hattori, N. (184) 57
Kanazawa, I., see Hashida, H. (190) 87 Koivula, T., see Luomala, M. (185) 123
Kanazawa, I., see Hagiwara, H. (193) 59 Kojima, S., see Tanaka, M. (188) 61
Kanda, F., see Yoshihara, T. (184) 149 Koleva, M., see Kostova, V. (192) 17
Kaneko, K., see Fujimoto, H. (187) 17 Komiyama, A., see Inaba, Y. (185) 89
Kang, D.-W., see Chu, K. (185) 27 Kondo, T., see Miwa, H. (193) 97
Kanzato, N., see Nakagawa, M. (184) 15 Kono, S., see Miyajima, H. (184) 197
Karitzky, J. and Ludolph, A.C. Korcezyn, A.D., see Wang, N. (184) 183
Imaging and neurochemical markers for diagnosis and disease pro- Korezyn, A.D., see Drory, V.E. (190) 17
gression in ALS (191) 35 Korezyn, A.D., see Drory, V.E. (191) 133
Kasner, S.E., see Cucchiara, B. (187) 81 Kornberg, A.J., see Lopate, G. (188) 67
Katayama, T., Aizawa, H., Kuroda, K., Suzuki, Y., Kikuchi, K., Kimura, Kornfeld, M., see Davis, L.E. (187) 61
T., Hashimoto, K. and Yahara, O. Kosaka, K., see Togo, T. (184) 71
Cortical silent period in the tongue induced by transcranial magnetic Kosaka, K., see Iseki, E. (185) 129
stimulation (193) 37 Kosaka, K., see Shiozaki, K. (193) 23
Kato, M., see Iseki, E. (185) 129 Koskiniemi, M., see Rantalaiho, T. (184) 169
Cumulative Author Index (2002) Volumes 184—194
Kostova, V. and Koleva, M. Li, Y., see Chen, J. (189) 49
Back disorders (low back pain, cervicobrachial and lumbosacral radic- Lichy, C., see Grau, A.J. (186) |
ular syndromes) and some related risk factors (192) 17 Lin, X. and Blumhardt, L.D.
Krampfl, K., Schlesinger, F., Wolfes, H., Dengler, R. and Bufler, J. Inflammation and atrophy in multiple sclerosis: MRI associations
Functional diversity of recombinant human AMPA type glutamate with disease course (189) 99
receptors: possible implications for selective vulnerability ofmotor Lindblom, U., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
neurons (191) 19 Trials (189) 3
Krismann, M., see Sindern, E. (186) 81 Lindsberg, P.J., see Sairanen, T.R. (186) 87
Kubota, T., see Oishi, A. (193) 151 Link, H., see Press, R. (190) 41
Kumai, Y., see Toyoda, K. (193) 147 Litchy, W.J., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
Kumamoto, T., see Shimazaki, R. (194) 55 Trials (189) 3
Kurahashi, K., see Tomiyama, M. (189) 65 Liu, L.A., see O’Brien, D.P. (189) 37
Kuroda, K., see Katayama, T. (193) 37 Liu, X.-F., Fawcett. J.R., Thorne, R.G., DeFor, T.A. and Frey II, W.H.
Kuroda, S., see Yokota, O. (194) 41 Intranasal administration of insulin-like growth factor-I] bypasses the
Kuroda, Y., see Satoh, J.-i. (189) 113 blood-brain barrier and protects against focal cerebral ischemic dam-
Kurokawa, T., see Tanaka, M. (188) 61 age (187) 91
Kushnir, M., Klein, C. and Rabey, J.M. Livramento, J.A., see Nitrini, R. (184) 163
H reflex behavior in Parkinson’s disease patients and patients with Livrea, P., see Avolio, C. (186) 65
extrapyramidal and pyramidal signs combined (186) 101 Lo, H.-S., Hogan, E.L. and Soong, B.-W.
Kusumi, M., see Mori, M. (185) 43 5'-Flanking region polymorphism of the neuronal nitric oxide syn-
Kusunoki, S., see Mizutani, K. (188) 9 thase gene with Parkinson’s disease in Taiwan (194) 11]
Kusunoki, S., see Hagiwara, H. (193) 59 Lo, Y.L., see Tan, E.K. (190) 95
Kuwana, M., see Suzuki, S. (189) 59 Lolli, F., see Press, R. (190) 41
Kyogashima, M., see Inaba, Y. (185) 89 Lopate, G., Kornberg, A.J.. Yue, J., Choksi, R. and Pestronk, A.
Anti-myelin associated glycoprotein antibodies: variability in patterns
of IgM binding to peripheral nerve (188) 67
Lopiano, L., see Perozzo, P. (192) 9
Lo Presti, R., see Caimi, G. (186) 23
Laatu, S., Revonsuo, A., Hamilidinen, P., Ojanen, V. and Ruutiainen, J. Love, S., see Perunovic, B. (185) 55
Visual object recognition in multiple sclerosis (185) 77 Low, P.A., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
Lacomblez, L., see Le Forestier, N. (185) 95 Trials (189) 3
Lacomblez, L., see Spreux-Varoquaux, O. (193) 73 Lu, M., see Chen, J. (189) 49
Laippala, P., see Luomala, M. (185) 123 Ludolph, A.C., see Karitzky, J. (191) 35
Lanotte, M., see Perozzo, P. (192) 9 Luomala, M., Lehtimaki, T., Elovaara, 1, Wang, X.-Y., Ukkonen, M.,
Lanzillo, B., see Perretti, A. (192) 35 Mattila, K., Laippala, P.. Koivula, T. and Hurme, M.
Lazeron, R.H.C., see Kalkers, N.F. (184) 155 A study of interleukin-1 cluster genes in susceptibility to and severity
Lazeron, R.H.C., see Kalkers, N.F. (187) 111 of multiple sclerosis (185) 123
Leary, S.M., see Dehmeshki, J. (185) 11
LeBlanc, A., see Nitrini, R. (184) 163
Lee, D.Y., see Jhoo, J.H. (184) 21
Lee, E.-J. and Hung, Y.-C.
Marked anemic hypoxia deteriorates cerebral hemodynamics and Maccario, M., see Durelli, L. (193) 17
brain metabolism during massive intracerebral hemorrhage (190) 3 Maeda, T., see Tomiyama, M. (189) 65
Lee, J.H., see Jhoo, J.H. (184) 21 Maisonobe, T., see Le Forestier, N. (185) 95
Lee, J.N., Rigby, S.A., Burchardt, F., Thornton, E.W., Dougan, C. and Malek, M.. see Tavakoli, M. (191) 95
Young, C.A. Malin, J.P., see Sindern, E. (186) 81
Quality of life issues in motor neurone disease: the development and Manabe, Y., Murakami, T., Iwatsuki, K., Narai, H., Warita, H., Hayashi,
validation of a coping strategies questionnaire, the MND Coping T., Shoji, M., Imai, Y. and Abe, K.
Scale (191) 79 Nocturnal blood pressure dip in CADASIL (193) 13
Lee, K.U., see Jhoo, J.H. (184) 21 Manabe, Y., see Murakami, T. (189) 45
Le Forestier, N.. Maisonobe, T.. Spelle, L.. Lesort, A., Salachas, F., Manca, MLL., see Siciliano, G. (191) 61
Lacomblez, L.. Samson, Y., Bouche, P. and Meininger, V. Mancardi, G., Hart, B., Roccatagliata, L., Brok, H., Giunti, D., Bontrop,
Primary lateral sclerosis: further clarification (185) 95 R., Massacesi, L., Capello, E. and Uccelli, A.
Le Forestier, N., see Spreux-Varoquaux, O. (193) 73 Demyelination and axonal damage in a non-human primate model of
Lehtimaki, T., see Luomala, M. (185) 123 multiple sclerosis (184) 41
Leigh, P.N., see Kiebert, G.M. (191) 87 Manganotti. P., Bortolomasi, M.. Zanette, G., Pawelzik, T., Giacopuzzi.
Leinsinger, G., see Bokde, A.L.W. (194) 35 M. and Fiaschi, A.
Lejon, V., see Bisser, S. (193) 127 Intravenous clomipramine decreases excitability of human motor cor-
Lemahieu, I., see De Reuck, J. (193) 1 tex. A study with paired magnetic stimulation (184) 27
Leshner, R., see Miller, R.G. (191) 127 Marbini, A., see Gemignani, F. (184) 1
Lesort, A., see Le Forestier, N. (185) 95 Marie, S.K., see Nitrini, R. (184) 163
Levine, D.N. and Rapalino, O. Marinou, K., see Meola, G. (193) 89
The pathophysiology of lumbar puncture headache (192) | Marouan, A., see Spreux-Varoquaux, O. (193) 73
Li, J., see Yu, K. (189) 23 Martin, J., see Fedetz, M. (190) 69
Li, Y., Chen, J. and Chopp, M. Martinelli-Boneschi, F., see Codella, M. (194) 71
Cell proliferation and differentiation from ependymal, subependymal Marui, W., see Togo, T. (184) 71
and choroid plexus cells in response to stroke in rats (193) 137 Marui, W., see Iseki, E. (185) 129
100 Cumulative Author Index (2002) Volumes 184-194
Maruyama, I., see Matsuyama, W. (186) 75 Miller, R.G., Moore, D.H., Dronsky, V., Bradley, W., Barohn, R., Bryan,
Maruyama, K., see Kametani, F. (188) 27 W.., Prior, T.W., Gelinas, D.F., lannaccone, S., Kissel, J., Leshner, R.,
Mase, G., Ros, S.. Gemma, A., Bonfigli, L., Carraro, N., Cazzato, G., Mendell, J., Mendoza, M., Russman, B., Samaha, F., Smith, S. and
Rolfo, M., Zanconati, F., Sepcic, J., Jurjevic, A., Pirulli, D., Boniotto, SMA Study Group
M., Zezlina, S., Crovella, S. and Amoroso, A. A placebo-controlled trial of gabapentin in spinal muscular atrophy
ALS with variable phenotypes in a six-generation family caused by (191) 127
leul44phe mutation in the SOD/ gene (191) 11 Miller, R.G., see Jackson, C.E. (191) 75
Masjuan, J., see Cid, C. (193) 103 Millsap, P., see Josephson, S.A. (188) 51
Massacesi, L., see Mancardi, G. (184) 41 Mimori, Y., see Naka, H. (193) 111
Masuda, N., see Hashida, H. (190) 87 Minamitani, H., see Ishikawa, M. (194) 59
Mata, S., see Press, R. (190) 41 Minohara, M., see Horiuchi, I. (193) 49
Mateo, I., see Berciano, J. (194) 75 Misra, U.K. and Kalita, J.
Matesanz, F., see Fedetz, M. (190) 69 Seizures in Japanese encephalitis (190) 57
Matsuda, M., Tabata, K.-i., Miki, J.. Ishigame, H., Asano, M. and Ikeda. Misu, K., see Hattori, N. (184) 57
S.-i. Misu, K.-i., see Yoshihara, T. (184) 149
Multiple sclerosis with secondary syringomyelia An autopsy report Mitchell, J.D., see Kiebert, G.M. (191) 87
(184) 189 Mitsumoto, H., see Albert, S.M. (191) 115
Matsumura, T., see Nakagawa, M. (184) 15 Miwa, H., Mizuno, Y. and Kondo, T.
Matsunaga, M., see Tomiyama, M. (189) 65 Fainilial hemifacial spasm: report of cases and review of literature
Matsuura, E., see Matsuyama, W. (186) 75 (193) 97
Matsuyama, W., Hashiguchi, T., Umehara, F., Matsuura, E.. Kawabata, Miyajima, H., Ouchi, Y., Sakamoto, M., Takahashi, Y., Kono, S. and
M., Arimura, K., Maruyama, I. and Osame, M. Suzuki, H.
Expression of vascular endothelial growth factor in tuberculous Increased anaerobic glycolysis in mitochondrial trifunctional protein-
meningitis (186) 75 deficient brain (184) 197
Matsuyama, W., see Nakagawa, M. (185) 31 Miyashita, F., see Nakagawa, M. (185) 31
Matsuzaki, T.. see Nakagawa, M. (184) 15 Mizuno, S., see Murakami, T. (189) 45
Mattila, K., see Luomala, M. (185) 123 Mizuno, Y., see Noda, K. (188) 95
Mayer, R.P. Mizuno, Y., see Miwa, H. (193) 97
The motor unit and electromyography—the legacy of Derek Denny- Mizusawa, H., see Ishida, K. (188) 43
Brown (189) 7 Mizutani, K., Oka, N., Kusunoki, S., Kaji, R., Mezaki, T., Akiguchi, I.
Mazzini, L., Balzarini, C., Colombo, R., Mora, G., Pastore, 1, De Am- and Shibasaki, H.
brogio, R. and Caligari, M. Sensorimotor demyelinating neuropathy with IgM antibody against
Effects of creatine supplementation on exercise performance and gangliosides GDla, GT1b and GM3 (188) 9
muscular strength in amyotrophic lateral sclerosis: preliminary results Moeller, H.-J.. see Bokde, A.L.W. (194) 35
(191) 139 Moggio, M., see Sironi, M. (186) 51
McCombe, P.A., see Harness, J. (187) 7 Moggio, M., see Bendotti, C. (191) 25
McManus, D.Q., see Josephson, S.A. (188) 51 Moller, H.-J., see Hampel, H. (194) 15
Medina, M.T. and Munsat, T. Moller, M., see Kamada, K. (186) 13
Continuing medical education in developing countries (190) | Monastero, R., Bettini, P.. Del Zotto, E., Cottini, E., Tincani, A.,
Meglic, B., Graus, F. and Grad, A. Balestrieri, G., Cattaneo, R., Camarda, R., Vignolo, L.A. and
Anti-Yo-associated paraneoplastic cerebellar degeneration in a man Padovani, A.
with gastric adenocarcinoma (185) 135 Prevalence and pattern of cognitive impairment in systemic lupus
Meininger, V., see Le Forestier, N. (185) 95 erythematosus patients with and without overt neuropsychiatric mani-
Meininger, V., see Spreux-Varoquaux, O. (193) 73 festations (184) 33
Melanson, M., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy Mondelli, M., Sicurelli, F.. Scarpini, C., Dotti, M.T. and Federico, A.
Trials (189) 3 Cerebrotendinous xanthomatosis: | 1-year treatment with chenodeoxy-
Melun, J.-P.. Morin, L.M., Muise, J.G. and DesRosiers, M. cholic acid in five patients. An electrophysiological study (190) 29
Color vision deficiencies in Gilles de la Tourette syndrome (186) 107 Montalenti, E., Imperiale, D., Rovera, A., Bergamasco, B. and Benna, P.
Mendell, J., see Miller, R.G. (191) 127 Clinical features, EEG findings and diagnostic pitfalls in juvenile
Mendell, J.R., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy myoclonic epilepsy: a series of 63 patients (184) 65
Trials (189) 3 Montana, M., see Caimi, G. (186) 23
Mendonga, R.A., see Nitrini, R. (184) 163 Monti Bragadin, L., see Zorzon, M. (187) 1
Mendoza, M., see Miller, R.G. (191) 127 Montirosso, R., Brambilla, D., Felisari, G., Sclaunich, F., Filipponi, E.,
Mennini, T., see Comoletti, D. (192) 61 Pozzoli, U. and Bresolin, N.
Meola, G., Sansone, V., Marinou, K., Cotelli, M., Moxley HI, R.T., Electrophysiologica! analysis of cognitive slowing in subjects with
Thornton, C.A. and De Ambroggi, L. mitochondrial encephalomyopathy (194) 3
Proximal myotonic myopathy: a syndrome with a favourable progno- Moore, D.H., see Jackson, C.E. (191) 75
sis? (193) 89 Moore, D.H., see Miller, R.G. (191) 127
Merren, M.D., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy Mora, G., see Mazzini, L. (191) 139
Trials (189) 3 Moran, M.A., see Garcia Gil, M.L. (192) 27
Messina, C., see Vita, G. (186) 45 Morandi, C., see Guidetti, D. (184) 203
Mezaki, T., see Mizutani, K. (188) 9 Moretti, R., see Zorzon, M. (187) |
Mezei, M., see Stewart, H. (191) 67 Mori, H., see Kametani, F. (188) 27
Miki, J., see Matsuda, M. (184) 189 Mori, M., Adachi, Y., Kusumi, M. and Nakashima, K.
Miklossy, J., see De Freitas, G.R. (193) 43 Spinocerebellar ataxia type 6: founder effect in Western Japan (185)
Miller, D.H., see Dehmeshki, J. (185) 11 43
Miller, D.H., see Hickman, S.J. (187) 35 Mori, M., see Shimazaki, R. (194) 55
Cumulative Author Index (2002) Volumes 184-194 101
Mori, T., see Shimazaki, R. (194) 55 Namekawa, M., Takiyama, Y., Sakoe, K., Shimazaki, H.. Amaike. M..
Morin, L.M., see Melun, J.-P. (186) 107 Niijima, K., Nakano, I. and Nishizawa, M.
Morris, J., see Grossman, M. (184) 123 A large Japanese SPG4 family with a novel insertion mutation of the
Morris, J.C., see Josephson, S.A. (188) 51 SPG4 gene: a clinical and genetic study (185) 63
Mosek, A., see Drory, V.E. (191) 133 Namekawa, M., see Shimazaki, H. (185) 101
Moseley, I.F., see Hickman, S.J. (187) 35 Narai, H., see Manabe, Y. (193) 13
Mowzoon, N., Sussman, A. and Bradley, W.G. Narayanaswami, P. and Bertorini, T.E.
Mycophenolate (CellCept) treatment of myasthenia gravis, chronic Progressive amyotrophy as a late complication of myelopathy (184)
inflammatory polyneuropathy and inclusion body myositis (185) 119 11
Moxley III. R.T., see Meola, G. (193) 89 Nasuelli, D., see Zorzon, M. (187) |
Muise, J.G., see Melun, J.-P. (186) 107 Nemoto, H., Nemoto, K., Sugimoto, H. and Kinoshita, M.
Munoz, A., see Aguilera, I. (192) 81 FK506 suppressed the inflammatory change of EAM in SJL/J mice
Munsat,. T., see Medina, M.T. (190) | (193) 7
Murai, H., see Horiuchi, I. (193) 49 Nemoto, K., see Nemoto, H. (193) 7
Murakami, T., Warita, H., Hayashi, T., Sato, K., Manabe, Y., Mizuno, S., Neudert, C., Wasner, M. and Borasio, G.D.
Yamane, K. and Abe, K. Patients’ assessment of quality of life instruments: a randomised study
A novel SOD1 gene mutation in familial ALS with low penetrance in of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral
females (189) 45 sclerosis (191) 103
Murakami, T., see Manabe, Y. (193) 13 Neundorfer, B., see Hecht, M.J. (186) 37
Murakawa, Y., see Zhang, W. (194) 21 Neville, H.E., see Sanjak, M. (191) 55
Murali, T., see Nair, K.P.S. (187) 77 Niijima, K., see Namekawa, M. (185) 63
Muramatsu, S.-i., see Namekawa, M. (187) 103 Nishioka, M., see Deguchi, K. (190) 61
Murgod, U.A., Saleem, Q., Anand, A., Brahmachari, S.K., Jain, S. and Nishizawa, M., see Namekawa, M. (185) 63
Muthane, U.B. Nishizawa, M., see Shimazaki, H. (185) 101
A clinical study of patients with genetically confirmed Huntington’s Nishizawa, M., see Namekawa, M. (187) 103
disease from India (190) 73 Nitrini, R., Mendonga, R.A., Huang, N., LeBlanc, A.. Livramento, J.A.
Murphy, C., see Kiebert, G.M. (191) 87 and Marie, S.K.
Murphy, J.R., see Sanjak, M. (191) 55 Diffusion-weighted MRI in two cases of familial Creutzfeldt—Jakob
Murphy, P.L., see Albert, S.M. (191) 115 disease (184) 163
Murri, L., see Siciliano, G. (191) 61 Noachtar, S., see Eisensehr, I. (186) 7
Musallam, S., see Wong, A.M.F. (189) 71 Noda, K., Okuma, Y., Fukae, J., Fujishima, K., Goto, K., Sadamasa, H.,
Musso, M., see Caimi, G. (186) 23 Yoshiike, T. and Mizuno, Y.
Musumeci, O., see Hadjigeorgiou, G.M. (194) 83 Sweet's syndrome associated with encephalitis (188) 95
Muthane, U.B., see Murgod, U.A. (190) 73 Nomura, S., see Yoshida, T. (184) 77
Muzio, V., see Comoletti, D. (192) 61 Nomura, T., Takeshima, T. and Nakashima, K.
Myers, D., see Jackson, C.E. (191) 75 Reduced pre-movement facilitation of motor evoked potentials in
spinocerebellar degeneration (187) 41
Nagaki, H., see Shimazaki, H. (185) 101 Nose, S., see Yokota, O. (194) 41
Nagamatsu, M., see Hattori, N. (184) 57
Nair, K.P.S., Taly, A.B., Rao, S. and Murali, T.
Afferent pathways of sympathetic skin response in spinal cord: a
clinical and electrophysiological study (187) 77 O’Brien, D.P., Johnson, G.C., Liu, L.A.. Guo, L.T., Engvall, E.. Powell.
Naka, H., Imon, Y., Ohshita, T., Honjo, K., Kitamura, T., Mimori, Y. and H.C. and Shelton, G.D.
Nakamura, S. Laminin a2 (merosin)-deficient muscular dystrophy and demyelinat-
Magnetization transfer measurements of cerebral white matter in ing neuropathy in two cats (189) 37
patients with myotonic dystrophy (193) 111 O’Brien, M., see Kiebert, G.M. (191) 87
Nakagawa, H., see Ono, S. (187) 27 O’Brien, P.C., see Ad Hoc Panel on Endpoints for Diabetic Neuropathy
Nakagawa, M., Matsuzaki, T., Suehara, M., Kanzato, N., Takashima, H., Trials (189) 3
Higuchi, I., Matsumura, T., Goto, K., Arahata, K. and Osame, M. Ochi, H., see Horiuchi, I. (193) 49
Phenotypic variation in a large Japanese family with Miyoshi myopa- Ochi, H., see Oishi, A. (193) 151
thy with nonsense mutation in exon 19 of dysferlin gene (184) 15 Ofuji, A., see Fujimoto, H. (187) 17
Nakagawa, M., Takashima, H., Umehara, F., Arimura, K.. Miyashita, F., Oggero, A., see Durelli, L. (193) 17
Takenouchi, N., Matsuyama, W. and Osame, M. Ohnuma, A., see Shimizu, H. (185) 39
Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an Ohshita, T., see Naka, H. (193) I11
entire deletion of the connexin 32 coding sequence (185) 31 Ohyagi, Y., see Oishi, A. (193) 151
Nakagawa, M., see Kikuchi, A. (193) 29 Oishi, A., Tobimatsu, S., Ochi, H., Ohyagi, Y.. Kubota, T., Taniwaki, T..
Nakamura, S., see Inaba, Y. (185) 89 Yamamoto, T., Furuya, H. and Kira, J.-i.
Nakamura, S., see Naka, H. (193) 111 Paradoxical lateralization of parasagittal spikes revealed by back
Nakano, I., see Namekawa, M. (185) 63 averaging of EEG and MEG in a case with epilepsia partialis continua
Nakano, I., see Shimazaki, H. (185) 191 (193) 151
Nakano, I., see Namekawa, M. (187) 103 Ojanen, V., see Laatu, S. (185) 77
Nakashima, K., see Mori, M. (185) 43 Oka, N., see Mizutani, K. (188) 9
Nakashima, K., see Nomura, T. (187) 41 Okamoto, K., see Hayashi, S. (188) 3
Nalini, A., see Shahani, N. (185) 109 Okita, N., see Kikuchi, A. (193) 29
Namekawa, M., Takiyama, Y., Ando, Y., Sakoe, K., Muramatsu, S.-i., Okuda, B., Kawabata, K., Tachibana, H., Sugita, M. and Tanaka. H.
Fujimoto, K.-i., Nishizawa, M. and Nakano, I. Postencephalitic pure anomic aphasia: 2-year follow-up (187) 99
Choreiform movements in spinocerebellar ataxia type 1 (187) 103 Okuma, Y., see Noda, K. (188) 95
102 Cumulative Author Index (2002) Volumes 184—194
Ono, S., Hu, J., Shimizu, N., Imai, T. and Nakagawa, H. Pozzoli, U., see Montirosso, R. (194) 3
Increased interleukin-6 of skin and serum in amyotrophic lateral Pracucci, G., see Di Carlo, A. (188) 85
sclerosis (187) 27 Pradat, P.F., see Spreux-Varoquaux, O. (193) 73
Onodera, Y., see Tateyama, M. (194) 29 Prelle, A., see Bendotti, C. (191) 25
Ooie. T.. see Hashida, H. (190) 87 Press, R., Mata, S., Lolli, F., Zhu, J., Andersson, T. and Link, H.
@ren, A., White, L.R. and Aasly, J. Temporal profile of anti-ganglioside antibodies and their relation to
Apoptosis in neurones exposed to cerebrospinal fluid from patients clinical parameters and treatment in Guillain-Barré syndrome (190)
with multiple sclerosis or acute polyradiculoneuropathy (186) 31 41 ‘
Osame, M., see Nakagawa, M. (184) 15 Preux, P.M., see Bisser, S. (193) 127
Osame, M., see Nakagawa, M. (185) 31 Prior, T.W., see Miller, R.G. (191) 127
Osame, M., see Matsuyama, W. (186) 75 Pruvo, J.P., see De Seze, J. (188) 37
Osborne, D., see Caselli, R.J. (189) 93 Pugliatti, M., see Sotgiu, S. (190) 99
Oshio, C., see Ishikawa, M. (194) 59
Osoegawa. M.. see Horiuchi, I. (193) 49
Quilty, R.D., see Perunovic, B. (185) 55
Ouchi, Y., see Miyajima, H. (184) 197
Rabey, J.M., see Kushnir, M. (186) 101
Padovani, A., see Monastero, R. (184) 33 Rabinowitz, R., see Wang, N. (184) 183
Palmarini, M.F., see Di Carlo, A. (188) 85 Raju, T.R., see Shahani, N. (185) 109
Pandey, R.M.. see Behari, M. (190) 49 Ramaekers, V.T., see Senderek, J. (192) 49
Pandit, L.. see Thomas, S.V. (188) 73 Rantalaiho, T., Farkkilaé, M., Vaheri, A. and Koskiniemi, M.
Pantoni, L., see Di Carlo, A. (188) 85 Acute encephalitis from 1967 to 1991 (184) 169
Papadimitriou, A., see Hadjigeorgiou, G.M. (194) 83 Rao, S., see Nair, K.P.S. (187) 77
Papalia, A., see Vita, G. (186) 45 Rapalino, O., see Levine, D.N. (192) |
Pascual, M., see Fedetz, M. (190) 69 Rapoport, S.I., see Hampel, H. (194) 15
Pasquali, L., see Siciliano, G. (191) 61 Rasmussen, H.B., Kelly, M.A., Francis, D.A. and Clausen, J.
Pastore, I.. see Mazzini, L. (191) 139 CTLA4 in multiple sclerosis. Lack of genetic association in a Euro-
Pastorini. E., see Siciliano, G. (191) 61 pean Caucasian population but evidence of interaction with HLA-DR2
Patel, M., see Hajat, C. (190) 79 among Shanghai Chinese (184) 143
Paterakis, K., see Hadjigeorgiou, G.M. (194) 83 Ravizza, T., see Comoletti, D. (192) 61
Pattee, G.L., see Ball, LJ. (191) 43 Regidor, I., see Cid, C. (193) 103
Pawelzik. T., see Manganotti, P. (184) 27 Reiber, H. and Peter, J.B.
Pellecchia, M.T., see Perretti, A. (192) 35 Cerebrospinal fluid analysis: disease-related data patterns and evalua-
Pels, H.. see Pohl, C. (190) 21 tion programs (184) 101
Penge. S., see Yilmaz, M. (184) 139 Reichhart, M., see De Freitas, G.R. (193) 43
Pender, M.P., see Harness, J. (187) 7 Reiman, E.M., see Caselli, R.J. (189) 93
Pera, J., see Szczudlik, A. (189) 105 Reis, A., see Grau, A.J. (192) 41
Perna, A.M., see Di Carlo, A. (188) 85 Rendell, M., Rizza, R.A., Service, F.J.. Thomas, P.K., Walk, D., Wang,
Perozzo, P.. Rizzone, M., Bergamasco, B., Castelli, L.. Lanotte, M., A.K., Wessel, K., Windebank, A.J.. Ziegler, D. and Zochodne, D.W.
Tavella, A., Torre, E. and Lopiano, L. (189) 3
Deep brain stimulation of the subthalamic nucleus in Parkinson’s Revonsuo, A., see Laatu, S. (185) 77
disease: comparison of pre- and postoperative neuropsychological Rigby, S.A., see Lee, JN. (191) 79
evaluation (192) 9 Ringel, S.P., see Sanjak, M. (191) 55
Perretti, A.. Pellecchia, M.T., Lanzillo, B., Campanella, G. and Santoro, Rizza, R.A., see Rendell, M. (189) 3
L; Rizzato, B., see Diomedi, M. (185) 49
Excitatory and inhibitory mechanisms in Wilson’s disease: investiga- Rizzone, M., see Perozzo, P. (192) 9
tion with magnetic motor cortex stimulation (192) 35 Road, J., see Stewart, H. (191) 67
Perunovic, B., Quilty, R.D., Athanasiou, A. and Love, S. Robotti, M.. see Sironi, M. (186) 51
Damage to intracranial optic pathways in fatal closed head injury in Rocca, M.A., see Codella, M. (194) 71
man (185) 55 Roccatagliata, L., see Mancardi, G. (184) 41
Pestronk, A., see Lopate, G. (188) 67 Rodolico, C., see Vita, G. (186) 45
Peter, J.B., see Reiber, H. (184) 101 Roelke, K., see Sanjak, M. (191) 55
Piccini, C., see Di Carlo, A. (188) 85 Roh, J.-K., see Chu, K. (185) 27
Piccolo, G., see Franciotta, D. (190) 11 Roldan, A.-N., see Aguilera, I. (192) 81
Pingree, M., see Greenlee, J.E. (184) 131 Rolfo, M., see Masé, G. (191) 11
Pirulli, D., see Masé, G. (191) 11 Romani, A., see Bergamaschi, R. (189) 13
Pisanello, A., see Guidetti, D. (184) 203 Rong, W., see Yu, K. (189) 23
Pohl. C.. Block, W., Traber, F., Schmidt, S., Pels, H., Grothe, C., Schild. Ros, S., see Masé, G. (191) 11
H.H. and Klockgether, T. Rosati, G., see Sotgiu, S. (190) 99
Proton magnetic resonance spectroscopy and transcranial magnetic Rosenfeld, J., see Jackson, C.E. (191) 75
stimulation for the detection of upper motor neuron degeneration in Rovaris, M., see Inglese, M. (188) 33
ALS patients (190) 21 Rovera, A., see Montalenti, E. (184) 65
Polman, C.H., see Kalkers, N.F. (184) 155 Rowland, L.P., see Albert, S.M. (191) 115
Polman, C.H., see Kalkers, N.F. (187) 111 Rudd, A.G., see Hajat, C. (190) 79
Polo, J.M., see Berciano, J. (194) 75 Rudi, J., see Grau, A.J. (186) 1
Porretto, F., see Caimi, G. (186) 23 Rudnik-Schéneborn, S., see Senderek, J. (192) 49
Powell, H.C., see O’Brien, D.P. (189) 37 Ruggieri, M., see Avolio, C. (186) 65